Click on a filter below to refine your search. Remove a filter to broaden your search.
The findings were seen among low-income individuals with diabetes and poor glycemic control.
The findings were seen even after controlling for sociodemographic and other health factors.
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Researchers devised a new way to ensure that older adults aren’t being overtreated or tested needlessly via unnecessary screenings.
Significant improvements were seen for produce consumption, physical activity, non-high-density lipoprotein cholesterol and HbA1c.
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss. The poll was among those aged 50 to 80.
Half of the participants reported at least one severe cardiovascular condition; the overall mortality rate was 19.8%.
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Caps are associated with a reduction in insulin costs, mainly driven by patients enrolled in health savings accounts.
The risk for type 2 diabetes was significantly reduced at a walking speed of 4 km/hour and greater based on dose-response analysis.